Trial intelligence / Profile preview

Antipyretics for Preventing Recurrences of Febrile Seizures

NCT00568217Phase 4Completed

Sponsor
University of Oulu
Start
Sep 1997
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of diclofenac, acetaminophen and ibuprofen in febrile seizure (FS) (5 arms), sponsored by University of Oulu. Primary endpoint: Recurrence of febrile seizure at 2 years. Started Sep 1997; status: completed.

02

Drugs

diclofenacacetaminophenibuprofen
03

Conditions

febrile seizure (FS)

Beyond the preview

Go deeper on NCT00568217.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00568217.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call